Laqmani A, Buhk J H, Henes F O, Klink T, Sehner S, von Schultzendorff H C, Hammerle D, Nagel H D, Adam G, Regier M
Department of Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rofo. 2013 Aug;185(8):749-57. doi: 10.1055/s-0033-1335577. Epub 2013 Jun 7.
To determine the image quality of an iterative reconstruction (IR) technique in low-dose MDCT (LDCT) of the chest of immunocompromised patients in an intraindividual comparison to filtered back projection (FBP) and to evaluate the dose reduction capability.
30 chest LDCT scans were performed in immunocompromised patients (Brilliance iCT; 20-40 mAs; mean CTDIvol: 1.7 mGy). The raw data were reconstructed using FBP and the IR technique (iDose4™, Philips, Best, The Netherlands) set to seven iteration levels. 30 routine-dose MDCT (RDCT) reconstructed with FBP served as controls (mean exposure: 116 mAs; mean CDTIvol: 7.6 mGy). Three blinded radiologists scored subjective image quality and lesion conspicuity. Quantitative parameters including CT attenuation and objective image noise (OIN) were determined.
In LDCT high iDose4™ levels lead to a significant decrease in OIN (FBP vs. iDose7: subscapular muscle 139.4 vs. 40.6 HU). The high iDose4™ levels provided significant improvements in image quality and artifact and noise reduction compared to LDCT FBP images. The conspicuity of subtle lesions was limited in LDCT FBP images. It significantly improved with high iDose4™ levels (> iDose4). LDCT with iDose4™ level 6 was determined to be of equivalent image quality as RDCT with FBP.
iDose4™ substantially improves image quality and lesion conspicuity and reduces noise in low-dose chest CT. Compared to RDCT, high iDose4™ levels provide equivalent image quality in LDCT, hence suggesting a potential dose reduction of almost 80%.
通过个体内比较迭代重建(IR)技术与滤波反投影(FBP)在免疫功能低下患者胸部低剂量MDCT(LDCT)中的图像质量,并评估其剂量降低能力。
对免疫功能低下患者进行30次胸部LDCT扫描(Brilliance iCT;20 - 40 mAs;平均CTDIvol:1.7 mGy)。原始数据使用FBP和设置为七个迭代水平的IR技术(iDose4™,飞利浦,贝斯特,荷兰)进行重建。30例用FBP重建的常规剂量MDCT(RDCT)作为对照(平均曝光:116 mAs;平均CDTIvol:7.6 mGy)。三名盲法放射科医生对主观图像质量和病变清晰度进行评分。确定包括CT衰减和客观图像噪声(OIN)在内的定量参数。
在LDCT中,高iDose4™水平导致OIN显著降低(FBP与iDose7:肩胛下肌139.4 vs. 40.6 HU)。与LDCT FBP图像相比,高iDose4™水平在图像质量、伪影和噪声降低方面有显著改善。LDCT FBP图像中微小病变的清晰度有限。高iDose4™水平(> iDose4)时显著改善。确定iDose4™水平6的LDCT与FBP的RDCT图像质量相当。
iDose4™在低剂量胸部CT中显著提高图像质量和病变清晰度并降低噪声。与RDCT相比,高iDose4™水平在LDCT中提供相当的图像质量,因此提示潜在剂量降低近80%。